Association between an Impaired Bone Marrow Vascular Microenvironment and Prolonged Isolated Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Association between an Impaired Bone Marrow Vascular Microenvironment and Prolonged Isolated Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation

Published:2014-08 Issue:8 Volume:20 Page:1190-1197
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Kong Yuan,Hu Yue,Zhang Xiao-Hui,Wang Ya-Zhe,Mo Xiao-Dong,Zhang Yuan-Yuan,Wang Yu,Han Wei,Xu Lan-Ping,Chang Ying-Jun,Huang Xiao-Jun

Funder

National Natural Science Foundation

Beijing Municipal Science and Technology

National High Technology Research Development

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference44 articles.

1. Secondary failure of platelet recovery after hematopoietic stem cell transplantation;Bruno;Biol Blood Marrow Transplant,2001

2. Prolonged isolated thrombocytopenia after hematopoietic stem cell transplantation: morphologic correlation;Bielski;Bone Marrow Transplant,1998

3. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status;Chang;Biol Blood Marrow Transplant,2009

4. A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation;Bernstein;Blood,1998

5. Graft-v-host disease is associated with autoimmune-like thrombocytopenia;Anasetti;Blood,1989

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors of early disease progression and decreased survival for multiple myeloma patients after upfront autologous stem cell transplantation;Annals of Hematology;2024-03-13

2. Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myeloma;Cytotherapy;2023-11

3. CD19/CD22 dual‐targeting chimeric antigen receptor T‐cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B‐cell acute lymphoblastic leukaemia delays platelet recovery and increases risks of cytomegalovirus and Epstein–Barr virus viremia after transplantation;Clinical and Translational Medicine;2023-10

4. The hematopoietic microenvironment: a network of niches for the development of all blood cell lineages;Journal of Leukocyte Biology;2023-06-30

5. CD19/CD22 dual-targeting Chimeric antigen receptor T cell therapy bridging to allogeneic hematopoietic stem cell transplantation for B-cell acute lymphoblastic leukemia delays platelet recovery and increases risks of cytomegalovirus and Epstein-Barr Virus viremia after transplantation;2023-04-13